tirzepatide
tirzepatide is listed in the FDA National Drug Code directory with 50 NDC codes, marketed under brand names including ZEPBOUND, Zepbound KwikPen, Mounjaro. Available dosage forms: injection, solution, powder.
Drug Details
- Generic Name
- tirzepatide
- Brand Names
- ZEPBOUND, Zepbound KwikPen, Mounjaro, Zepbound, Mounjaro KwikPen, MOUNJARO
- Application Number
- NDA217806
- Sponsor
- BSP Pharmaceuticals SpA
- NDC Codes
- 50
- Dosage Forms
- INJECTION, SOLUTION, POWDER
- Routes
- SUBCUTANEOUS
- Active Ingredients
- TIRZEPATIDE
Indications and Usage
1 INDICATIONS AND USAGE MOUNJARO ® is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. MOUNJARO ® is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. ( 1 )